Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News

November 17, 2010 - Results from the GRAVITAS Trial found that doubling the maintenance dose of clopidogrel ...

Home November 17, 2010
Home
News

November 16, 2010 โ€“ Results from the ROCKET AF trial showed that rivaroxaban given once daily is superior at ...

Home November 16, 2010
Home
News

November 8, 2010 โ€“ The American College of Cardiology (ACC) and American Heart Association (AHA) issued a joint ...

Home November 08, 2010
Home
News

October 25, 2010 - A post-hoc-analysis from JUPITER, published in the European Heart Journal, shows rosuvastatin ...

Home October 25, 2010
Home
News

October 25, 2010 โ€“ A new study shows that an intensive population management program that matches heart disease ...

Home October 25, 2010
Home
News

October 20, 2010 - The U.S. Food and Drug Administration (FDA) approved a new drug to help prevent stroke and ...

Home October 20, 2010
Home
Technology

October 15, 2010 โ€“ The U.S. Food and Drug Administration (FDA) has approved an abbreviated new drug application ...

Home October 15, 2010
Home
News

October 13, 2010 โ€“ A recall was issued for bottles of 40 mg Lipitor, due to a small number of reports of an ...

Home October 13, 2010
Home
News

October 13, 2010 โ€“ The anti-obesity drug sibutramine will be withdrawn from the U.S. market after a study found it ...

Home October 13, 2010
Home
News

October 8, 2010 โ€“ New data from the HORIZONS-AMI trial shows that administering the anticoagulant bivalirudin ...

Home October 08, 2010
Home
News

October 7, 2010 - Taking medication at night instead of in the morning significantly increases efficacy in ...

Home October 07, 2010
Home
Technology

October 4, 2010 โ€“ The U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee ...

Home October 04, 2010
Home
News

September 24, 2010 - Trial data have established the safety of a reversible PAR-1 thrombin receptor antagonist in ...

Home September 24, 2010
Home
Feature | Dave Fornell

A new class of antiplatelet therapy drug pending U.S. Food and Drug Administration (FDA) clearance may offer ...

Home September 15, 2010
Home
News

September 15, 2010 โ€“ A study evaluating the level of platelet aggregation achieved after switching from ...

Home September 15, 2010
Home
Subscribe Now